Happy New Year 2025 – A Year of Growth and Innovation
As we bid farewell to the past year and step into 2025, CHICO Pharmaceutical would like to extend our warmest wishes to all our partners, clients, and friends. May the new year bring you health, happiness, and prosperity!
Looking back at the year gone by, we are grateful for the continued trust and collaboration that have allowed us to grow and expand. CHICO has remained dedicated to our mission of providing high-quality CDMO services and manufacturing premium pharmaceutical intermediates for key therapeutic areas such as oncology, diabetes, and cardiovascular diseases. Our expertise in the production of "TINIB, LIPTIN, LIFLOZIN, XABAN" series intermediates has been a cornerstone of our success, and we are proud of our ongoing commitment to innovation and excellence.
2025 promises to be a year full of new opportunities and challenges. As a high-tech enterprise based in the national-level chemical industrial park in Anqing, we are poised for continued growth. Our state-of-the-art facilities, including multifunctional production workshops for high-end pharmaceutical intermediates and general API manufacturing units, alongside our research center in Nanjing, position us to remain at the forefront of pharmaceutical innovation.
We look forward to strengthening our partnerships and contributing to the healthcare industry’s progress in the coming year. Together, let’s make 2025 a year of achievements and breakthroughs.
Once again, we wish you all a prosperous and healthy New Year!
Warm regards,
The CHICO Team
International Department:
Copyright(C)2018 Anqing Chico Pharmaceutical Co., Ltd.
Supported byChinaChemNet
